(Q34074969)

30 July 2017

1 reference

title

An assessment of levetiracetam as an anti-epileptic drug (English)

1 reference

30 July 2017

1 reference

Jain KK

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

1611-1624

1 reference

Clinical pharmacokinetics of new antiepileptic drugs

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

The antiepileptic drug AWD 131-138 stimulates different recombinant isoforms of the rat GABA(A) receptor through the benzodiazepine binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

The anticonvulsant effects of the enantiomers of losigamone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

The disposition of valproyl glycinamide and valproyl glycine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1611

10.1517/13543784.9.7.1611

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference